The role of social support on the relationships between internet use and sleep problems in adolescents during COVID-19 pandemic: a multicentre study.

BACKGROUND: This study examines the frequency of problematic internet use and sleep problems in adolescents aged 14-18 years during the COVID-19 pandemic and identifies the impact of factors such as sociodemographic characteristics, internet habits, changes in daily life, and perceived social support on these problems. METHODS: This multicentre study was a questionnaire-based online survey study. The questionnaire included the Young Internet Addiction Scale, the Pittsburgh Sleep Quality Index, and the Multidimensional Scale of Perceived Social Support, as well as questions about demographic information, internet habits, and changes in daily life during pandemic. Several multivariate Backward logistic regression models were run to determine the variables that predicted problematic internet use and poor sleep quality. RESULTS: It was determined that the frequency of problematic internet use was 15.5%, and the frequency of poor sleep quality was 47.8%. Poor sleep quality was found 2.5 times higher in problematic internet users. The perceived social support was found insufficient in adolescents with problematic internet use and poor sleep quality. Various factors such as the excessive use of internet and social media, low school success, lack of physical activity, lack of rules for internet use at home, and worsening of relationships with parents were found to be predictive factors for these problems. CONCLUSIONS: Problematic internet use during the pandemic is associated with worsening sleep quality in adolescents. It is important to create special interventions for problematic internet use and sleep problems that develop in adolescents as a result of restrictions during the pandemic.

Latent profile analysis of COVID-19 fear, depression, anxiety, stress, mindfulness, and resilience.

The purpose of the current study was to identify latent profiles of COVID-19 fear, depression, anxiety, stress, mindfulness, and resilience among university students. A total of 506 university undergraduate and graduate students from various universities were recruited through online platforms in Turkey. Data were collected utilizing self-report scales and were analyzed utilizing latent profile analysis. Results indicated significant relationships among COVID-19 fear, depression, anxiety, stress, resilience, and mindfulness. A three-class solution was adapted to fit the current data. Findings revealed that 46% of the participants were classified into the high COVID-19 fear and medium psychological symptoms profile. Also, 38% of the participants were identified as low psychological symptoms and high mindfulness and resilience. Additionally, 16% of the participants were classified as high COVID-19 fear, psychological symptoms and low mindfulness and resilience. Female gender was positively associated with COVID-19 fear, depression, anxiety, and stress. Life satisfaction and social support were positively associated with the mindfulness and resilience, and were negatively related to COVID-19 fear, depression, anxiety, and stress.

Psychopharmacological treatment in COVID-19 pandemic

The COVID-19 infection is still active both worldwide and in our country. Hereafter, it is going to have marked effects on clinical psychiatric practice. So, it is very important to consider the interactions of psychotropic drugs used in the COVID-19 pandemic in patients receiving psychiatric treatment or planned to start psychiatric treatment. There is still no cure for COVID-19 infection and treatment algorithms change over time. Moreover, studies on drug interactions between the drugs used in COVID-19 treatment and psychotropic drugs to guide the clinician are limited. In this regard, it is thought that it is important for psychiatrists to keep up with the current literature knowledge while planning psychotropic medication during the pandemic process, which is expected to continue for a long time. In this article, the mechanisms of action and interactions of frequently used drugs in the treatment of COVID-19 with psychotropic drugs such as hydroxychloroquine, favipiravir, oseltamivir, remdesivir, tocilizumab and azithromycin are reviewed. Also regardless of drug interactions, the antiviral effects of chlorpromazine and lithium and their place in the potential treatment of COVID-19 are mentioned and potential problems that psychiatric therapies may cause in these patients are discussed. (PsycInfo Database Record (c) 2021 APA, all rights reserved) Abstract (Turkish) COVID-19 enfeksiyonu tum dunyada ve ulkemizde halen etkisini surdurmekte olup onumuzdeki surecte psikiyatri pratiginde dikkate alinmasi gerekecektir. Bu acidan psikiyatrik tedavi almakta olan ya da psikiyatrik tedavi baslanmasi planlanan hastalarda COVID-19 pandemisinde kullanilan ilaclarin psikotrop ilaclarla etkilesimlerinin ele alinmasi oldukca onemlidir. COVID-19 enfeksiyonunun halen kesin bir tedavisi bulunmamakta ve tedavi algoritmalari zaman icerisinde degisiklik gostermektedir. Ayrica COVID-19 tedavisinde kullanilan bazi ilaclarin psikotroplarla etkilesimlerine dair klinisyene yol gosterecek calismalar kisitlidir. Bu acidan uzun bir sure daha devam etmesi beklenen pandemi surecinde psikiyatri hekimlerinin psikotrop ilac tedavilerini planlarken bu konuda mevcut literatur bilgisine hakim olmalarinin onemli oldugu dusunulmektedir. Buradan yola cikilarak bu yazida;hidroksiklorokin, favipiravir, oseltamivir, remdesivir, tosilizumab ve azitromisin gibi COVID-19 tedavisinde sik kullanilan ilaclarin etki mekanizmalari ve psikotrop ilaclarla etkilesimleri gozden gecirilmistir. Ayrica klorpromazin ve lityumun antiviral etkilerine ve COVID-19'un potansiyel tedavisindeki yerine deginilmis;ilac etkilesimlerinden bagimsiz olarak bu hastalarda psikiyatrik tedavilerin yol acabilecegi olasi sorunlar da tartisilmistir. (PsycInfo Database Record (c) 2021 APA, all rights reserved)